Clinical trial
A Multicentric, Single Arm, Prospective, Stratified Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection
NCT04253366 is registered in ClinicalTrials.gov with Umbria Bioengineering Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentric, Single Arm, Prospective, Stratified Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection
- Lead sponsor
- Umbria Bioengineering Technologies
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 16, 2020
- Completion date
- August 20, 2021
- Enrollment
- 353 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer